Skip to main content

Advertisement

SpringerLink
Log in

Attention deficit hyperactivity disorder (ADHD) and substance use disorders

  • Published:
Current Psychiatry Reports Aims and scope Submit manuscript

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common childhood disorder that often continues to manifest symptoms into adulthood. In children and adults, this condition may contribute to addictive vulnerability. Several factors are common to the developmental psychopathology of these conditions, suggesting an underlying deficit in behavioral regulation as an explanation for this comorbidity. Developmentally, faulty learning processes or attempts to self-medicate dysfunctional behavior may contribute to the pathogenesis of substance use disorders. Substance abuse itself also may contribute to the development of attentional deficits and behavioral dysregulation through direct (eg, prenatal or self-inflicted exposures to neurotoxic substances) and indirect (eg, poverty, neglect, abuse) mechanisms. Because ADHD can be identified prior to the peak onset of substance use, effective treatment of this common disorder may reduce the development of substance use disorders. Adult ADHD may also contribute to the development and maintenance of substance use disorders Substance abuse patients may particularly benefit from treatment of this comorbidity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Zito JM, dos Reis S, Gardner JF, et al.: Trends in the prescribing of psychotropic medications to preschoolers. JAMA 2000, 283:1025–1030.

    Article  PubMed  CAS  Google Scholar 

  2. Wilens TE, Biederman J: Attention deficit hyperactivity disorder. In Disruptive Behavior Disorders in Children and Adolescents. Edited by Hendren R. Washington, DC: American Psychiatric Press; 1999:1–46. Excellent study.

    Google Scholar 

  3. Levin FR, McDowell DM, Kleber HD: Methylphenidate treatment for cocaine abusers with adult attention deficit hyperactivity disorder: a pilot study. J Clin Psychiatry 1998, 59:300–305. A good article.

    PubMed  CAS  Google Scholar 

  4. Emrick C: Alcoholics Anonymous and other 12 step groups. In Textbook of Substance Abuse Treatment. Edited by Galanter M, Kleber HD. Washington, DC: American Psychiatric Press; 1999:403–412.

    Google Scholar 

  5. DeLeon G: Therapeutic communities. In Textbook of Substance Abuse Treatment. Edited by Galanter M, Kleber HD. Washington, DC: American Psychiatric Press; 1999:447–464.

    Google Scholar 

  6. Steiner H, Wilson J: Conduct disorder. In Disruptive Behavior Disorders in Children and Adolescents. Edited by Hendren R. Washington, DC: American Psychiatric Press; 1999:47–98.

    Google Scholar 

  7. Jensen PS, Kettle L, Roper MT, et al.: Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 1999, 38:797–804.

    Article  PubMed  CAS  Google Scholar 

  8. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  9. Riggs PD, Whitmore EA: Substance use disorders and disruptive behavior disorders. In Disruptive Behavior Disorders in Children and Adolescents. Washington DC: American Psychiatric Press; 1999:133–173. A good review.

    Google Scholar 

  10. Wilens TE, Biederman J, Mick E: Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 1998, 7:156–163. A good article.

    Article  PubMed  CAS  Google Scholar 

  11. Kaminer Y, Tarter RE: Adolescent substance abuse. In Textbook of Substance Abuse Treatment. Washington, DC: American Psychiatric Press; 1999:465–474.

    Google Scholar 

  12. Kirby KN, Petry NM, Bickel WK: Heroin addicts have higher discount rates for delayed rewards than non-drug using controls. J Exp Psychol Gen 1999, 128:78–87.

    Article  PubMed  CAS  Google Scholar 

  13. Brown TE: Attention-Deficit Disorders and Comorbidities in Children, Adolescents and Adults. Washington, DC: American Psychiatric Press; 2000.

    Google Scholar 

  14. Crome IB: Treatment interventions-looking towards the millennium. Drug Alcohol Depend 1999, 55:247–263.

    Article  PubMed  CAS  Google Scholar 

  15. Colder CR, Chassin L: The psychosocial characteristics of alcohol users versus problem users. Dev Psychopathol 1999, 11:321–348.

    Article  PubMed  CAS  Google Scholar 

  16. Costa FM, Jessor R, Turbin MS: Transition into adolescent problem drinking: the role of psychosocial risk and protective factors. J Stud Alcohol 1999, 60:480–490.

    PubMed  CAS  Google Scholar 

  17. Mayes LC, Bornstein MH: The development of children exposed to cocaine. In Developmental Psychopathology. Edited by Luthar SS, Burack JA, Cicchetti D, Weisz J. New York: Cambridge University Press; 1997:166–188.

    Google Scholar 

  18. Wasserman GA, Kline JK, Bateman DA, et al.: Prenatal cocaine exposure and school age intelligence. Drug Alcohol Depend 1998, 50:203–210.

    Article  PubMed  CAS  Google Scholar 

  19. Weinberg NZ: Cognitive and behavioral deficits associated with parental alcohol use. J Am Acad Child Adolesc Psychiatry 1997, 36:1177–1186.

    Article  PubMed  CAS  Google Scholar 

  20. Weissman MM, Warner V, Wickramaratne PJ, Kandel DB: Maternal smoking during pregnancy and psychopathology in offspring into adulthood. J Am Child Adolesc Psychiatry 1999, 38:892–899.

    Article  CAS  Google Scholar 

  21. Clark DB, Kirisci L, Moss HB: Early adolescent gateway drug use in sons of fathers with substance use disorders. Addict Behav 1998, 23:561–566.

    Article  PubMed  CAS  Google Scholar 

  22. Clark DB, Parker AM, Lynch KG: Psychopathology and substance-related problems during early adolescence: a survival analysis. J Clin Child Psychol 1999, 28:333–341.

    Article  PubMed  CAS  Google Scholar 

  23. Rutter M, Giller H, Hagell A: Antisocial Behavior by Young People. New York: Cambridge University Press; 1998. Excellent book on ADHD.

    Google Scholar 

  24. Dawes MA, Tarter RE, Kirisci L: Behavioral self-regulation: correlates and 2 year follow-ups for boys at risk for substance abuse. Drug Alcohol Depend 1997, 45:165–176.

    Article  PubMed  CAS  Google Scholar 

  25. Cloninger CR, Sigvardsson S, Bohman M: Childhood personality predicts alcohol abuse in young adults. Alcohol Clin Exp Res 1988, 12:494–505.

    Article  PubMed  CAS  Google Scholar 

  26. Tarter RE, Kirisci L, Hegedus A, et al.: Heterogeneity of adolescent alcoholism. In Types of Alcoholics: Evidence from Clinical, Experimental and Genetic Research. Edited by Babor TF, Hesselbrock V, Meyer RE, et al. New York: Annals of the New York Academy of Science; 1994:172–180.

    Google Scholar 

  27. Faraone SV, Biederman J, Spencer T, et al.: Attention deficit/ hyperactivity disorder in adults: an overview. Biol Psychiatry 2000, 48:9–20.

    Article  PubMed  CAS  Google Scholar 

  28. Wilson JJ, Rojas N, Carrion V, Steiner H: Criminal recidivism and substance abuse: aprospective study of delinquents. Child Psychiatry Hum Dev 2001, 31:297–312.

    Article  PubMed  CAS  Google Scholar 

  29. Faraone SV, Biederman J, Weiffenbach B, et al.: Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. Am J Psychiatry 1999, 156:768–770.

    PubMed  CAS  Google Scholar 

  30. Lahoste GJ, Swanson JM, Wigal SB, et al.: Dopamine D4 receptor gene polymophism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996, 1:121–124.

    PubMed  CAS  Google Scholar 

  31. Cook EH, Stein MA, Krasowshi MD, et al.: Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genetics 1995, 56:993–998.

    CAS  Google Scholar 

  32. Gill M, Daly G, Heron S, et al.: Confirmation of association between attention deficit disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997, 2:311–313.

    Article  PubMed  CAS  Google Scholar 

  33. Winsberg BG, Comings DE: Association of the dopamine transporter gene (DAT1) with poor methyphenidate response. J Am Acad Child Adolesc Psychiatry 1999, 38:1474–1477.

    Article  PubMed  CAS  Google Scholar 

  34. Dougherty DD, Bonab AA, Spencer TJ, et al.: Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999, 354:2132–2133.

    Article  PubMed  CAS  Google Scholar 

  35. Gardner EL: Brain reward mechanisms. In Substance Abuse, A Comprehensive Textbook. Baltimore, MD: Williams & Wilkins; 1997:51–84.

    Google Scholar 

  36. Levin FR, Kleber HD: Attention-deficit hyperactivity disorder and substance abuse: relationships and implications for treatment. Harv Rev Psychiatry 1995, 2:246–258.

    PubMed  CAS  Google Scholar 

  37. Lambert NM, Hartsough CS: Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learning Disabilities 1998, 31:533–544.

    Article  CAS  Google Scholar 

  38. Moss HB, Lynch KG: Comorbid disruptive behavior symptoms and their relationship to adolescent alcohol disorders. Drug Alcohol Depend 2001, 64:75–83.

    Article  PubMed  CAS  Google Scholar 

  39. Paternite CE, Loney J, Salisbury H, Whaley MA: Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. J Child Adolesc Psychopharmacology 1999, 9:169–184.

    CAS  Google Scholar 

  40. Greenfield B, Hectman L, Weiss G: Two subgroups of hyperactives as adults: correlations of outcome. Can J Psychiatry 1998, 33:505–508.

    Google Scholar 

  41. Manuzza S, Klein RG: Long term prognosis in attention deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 2000, 9:711–726. Very important paper.

    Google Scholar 

  42. Murphy K, Barkley RA: Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Attention Disord 1996, 1:147–161.

    Article  Google Scholar 

  43. Biederman J, Wilens TE, Mick E, et al.: Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998, 44:269–273.

    Article  PubMed  CAS  Google Scholar 

  44. Carroll KM, Rounsaville BJ: History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993, 34:75–86.

    Article  PubMed  CAS  Google Scholar 

  45. Deas D, Thomas SE: An overview of controlled studies of adolescent substance abuse treatment. Am J Addict 2001, 10:178–189.

    Article  PubMed  CAS  Google Scholar 

  46. Horner BR, Scheibe KE: Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse. J Am Child Adolesc Psychiatry 1997, 36:30–36.

    Article  CAS  Google Scholar 

  47. Applegate B, Lahey B, Hart E, et al.: Validity of the age of onset criterion for attention-deficit/hyperactivity disorder: a report from the DSM-IV field trials. J Am Child Adolesc Psychiatry 1997, 36:1211–1221.

    CAS  Google Scholar 

  48. Barkley RA, Biederman J: Toward a broader definition of the age of onset criterion for attention-deficit hyperactivity disorder. J Am Child Adolesc Psychiatry 1997, 36:1204–1210.

    CAS  Google Scholar 

  49. Wender PH, Garfinkel BD: Attention-deficit hyperactivity disorder: adult manifestations. In Comprehensive Textbook of Psychiatry. Baltimore, MD: Williams & Wilkins; 1989:1837–1841.

    Google Scholar 

  50. Levin FR, Evans SM, Kleber HD: Prevalence of adult attentiondeficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998, 52:15–25.

    Article  PubMed  CAS  Google Scholar 

  51. DuPaul GJ, McGoey KE, Eckert TL, VanBrakle J: Preschool children with attention-defict/hyperactivity disorder: impairments in behavioral, social and school functioning. J Am Acad Child Adolesc Psychiatry 2000, 40:508–515.

    Article  Google Scholar 

  52. Biederman J, Faraone SV, Keenan K, et al.: Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990, 29:526–533.

    Article  PubMed  CAS  Google Scholar 

  53. Biederman J, Faraone SV, Keenan SV, et al.: Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Arch Gen Psychiatry 1992, 49:728–738.

    PubMed  CAS  Google Scholar 

  54. Spencer T, Biederman J, Wilens T, Faraone SV: Is attentiondeficit hyperactivity disorder in adults a valid disorder? Harv Rev Psychiatry 1994, 1:326–335.

    PubMed  CAS  Google Scholar 

  55. Brown TE: Attention-deficit disorders and comorbidities in children, adolescents and adults. Washington, DC:American Psychiatric Press; 2000.

    Google Scholar 

  56. Rubia K, Smith A: Attention deficit hyperactivity disorder: current findings and treatment. Curr Opin Psychiatry 14:309–316.

  57. Jensen PS, Hinshaw SP, Swanson JM, et al.: Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr 2001, 22:60–73. Very important paper.

    PubMed  CAS  Google Scholar 

  58. Spencer T, Wilens T, Biederman J, et al.: A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995, 52:434–443.

    PubMed  CAS  Google Scholar 

  59. Pelham WE, Gnagy EM, Burrows-Maclean L, et al.: Once-a-day Concerta methylphenidate versus three-times daily methylyphenidate in laboratory and natural settings. Pediatrics 2001, 107:E105.

    Article  PubMed  CAS  Google Scholar 

  60. Popper CW: Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin North Am 2000, 9:605–646. An excellent paper.

    CAS  Google Scholar 

  61. Wilens TE, Spencer TJ, Biederman J, et al.: A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001, 158:282–288.

    Article  PubMed  CAS  Google Scholar 

  62. Wilens TE, Biederman J, Prince J, et al.: Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996, 153:1147–1153.

    PubMed  CAS  Google Scholar 

  63. Spencer T, Biederman J, Wilens T, et al.: Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1998, 155:693–695.

    PubMed  CAS  Google Scholar 

  64. Wilens TE, Biederman J, Spencer TJ, et al.: Controlled trial of high doses of pemoline for adults with attention-deficit/ hyperactivity disorder. J Clin Psychopharmacology 1995, 3:257–264.

    Google Scholar 

  65. Findlay RL, Schwartz MA, Flannery DJ, Manos MJ: Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial. J Clin Psychiatry 1996, 57:184–189.

    Google Scholar 

  66. Wilens TE, Biederman J, Spencer TJ, Prince J: Pharmacotherapy of adult attention deficit disorder: a review. J Clin Psychopharmarmacology 1995, 15:270–279.

    Article  CAS  Google Scholar 

  67. Riggs PD, Leon SL, Mikulich SK, Pottle LC: An open trial for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:1271–1278. A good article.

    Article  PubMed  CAS  Google Scholar 

  68. Levin FR, Evans SM, McDowell DM, et al.: Bupropion treatment for cocaine abusers and adult attention deficit hyperactivity disorder. J Addict Behav 2001, In press. A nice review.

  69. Margolin A, Kosten TR, Avants SK, et al.: A multicenter trial of bupropion for cocaine dependence in methadonemaintained patients. Drug Alcohol Depend 1995, 40:125–131.

    Article  PubMed  CAS  Google Scholar 

  70. Fischman MW, Foltin RW, Nestadt G, Pearlson GD: Effects of desipramine maintenance on cocaine self-administration in humans. J Pharmacol Exp Ther 1990, 253:760–770.

    PubMed  CAS  Google Scholar 

  71. Carroll KM, Nich C, Rounsaville BJ: Differential symptom reduction in depressed cocaine abusers treated with psychotherapy and pharmacotherapy. J Nerv Ment Dis 1995, 183:251–259.

    Article  PubMed  CAS  Google Scholar 

  72. Kosten TR, Morgan CM, Falcione J, Schottenfeld RS: Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry 1992, 49:894–898.

    PubMed  CAS  Google Scholar 

  73. Mattes JA, Boswell L, Oliver H: Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 1984, 41:1059–1063.

    PubMed  CAS  Google Scholar 

  74. Grabowski J, Roache JD, Schmitz JM, et al.: Replacement medication for cocaine dependence: methylphenidate. J Clin Psychopharmacol 1997, 17:485–488.

    Article  PubMed  CAS  Google Scholar 

  75. Evans S, Levin FR: Unpublished data. New York: NY State Psychiatric Institute; 2001.

  76. Levin FR, Evans SM, McDowell D, Kleber HD: Methylphenidate treatment for cocaine abusers with adult attention-deficit/ hyperactivity disorder: a pilot study. J Clin Psychiatry 1998, 59:300–305.

    PubMed  CAS  Google Scholar 

  77. Castenda R, Levy R, Hardy M, Trujilio M: Long-acting stimulants for the treatment of ADHD in cocaine-dependent adults. Psychiatr Serv 2000, 51:169–171.

    Article  Google Scholar 

  78. Gawin F, Riordan C, Kleber H: Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 1985, 11:193–197.

    PubMed  CAS  Google Scholar 

  79. Grabowski J, Roache JD, Schmitz JM, et al.: Replacement medication for cocaine dependence: Methylphenidate. J Clin Psychopharmacol 1997, 17:485–488.

    Article  PubMed  CAS  Google Scholar 

  80. Pelham WE, Sams SE: Behavior modification. In Child and Adolescent Psychiatric Clinics of North America. Edited by Weiss G. Philadelphia: WB Saunders; 1992:505–518.

    Google Scholar 

  81. Weinstein CS: Cognitive remediation strategies: an adjunct to the psychotherapy of adults with Attention-deficit hyperactivity disorder. J Psychother Pract Res 1994, 3:44–57.

    Google Scholar 

  82. Aviram RB, Rhum M, Levin FR: Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder. J Psychother Pract Res 2001, 10:179–186.

    PubMed  CAS  Google Scholar 

  83. Khantzian EJ, Gawin FH, Riordan C, Kleber HD: Methylphenidate treatment for cocaine dependence: a preliminary report. J Subst Abuse 1984, 1:107–112.

    Article  CAS  Google Scholar 

  84. Wender PH: ADHD. In Children and Adults. New York: Oxford University Press; 2000.

    Google Scholar 

  85. Pliszka SR, Carlson C, Swanson JT: ADHD with comorbid managment. In Clinical Assessment and Mangement. New York: Guilford Press; 1999.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, New York State Psychiatric Institute, 1051 Riverside Drive, 10032, New York, NY, USA

    Jeffrey J. Wilson MD & Frances R. Levin MD

Authors
  1. Jeffrey J. Wilson MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frances R. Levin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, J.J., Levin, F.R. Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Curr Psychiatry Rep 3, 497–506 (2001). https://doi.org/10.1007/s11920-001-0044-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11920-001-0044-8

Keywords

Search

Navigation